Author Correction: Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
- PMID: 38961306
- DOI: 10.1038/s41586-024-07595-7
Author Correction: Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
Erratum for
-
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase.Nature. 2024 May;629(8011):435-442. doi: 10.1038/s41586-024-07318-y. Epub 2024 Apr 24. Nature. 2024. PMID: 38658751
Similar articles
-
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase.Nature. 2024 May;629(8011):435-442. doi: 10.1038/s41586-024-07318-y. Epub 2024 Apr 24. Nature. 2024. PMID: 38658751
-
Identification of 2-Sulfonyl/Sulfonamide Pyrimidines as Covalent Inhibitors of WRN Using a Multiplexed High-Throughput Screening Assay.Biochemistry. 2023 Jul 18;62(14):2147-2160. doi: 10.1021/acs.biochem.2c00599. Epub 2023 Jul 5. Biochemistry. 2023. PMID: 37403936 Free PMC article.
-
Non-enzymatic function of WRN RECQL helicase regulates removal of topoisomerase-I-DNA covalent complexes and triggers NF-κB signaling in cancer.Aging Cell. 2022 Jun;21(6):e13625. doi: 10.1111/acel.13625. Epub 2022 May 18. Aging Cell. 2022. PMID: 35582959 Free PMC article.
-
Chemoproteomic methods for covalent drug discovery.Chem Soc Rev. 2021 Aug 2;50(15):8361-8381. doi: 10.1039/d1cs00231g. Chem Soc Rev. 2021. PMID: 34143170 Free PMC article. Review.
-
Reimagining Druggability Using Chemoproteomic Platforms.Acc Chem Res. 2021 Apr 6;54(7):1801-1813. doi: 10.1021/acs.accounts.1c00065. Epub 2021 Mar 18. Acc Chem Res. 2021. PMID: 33733731 Review.
Cited by
-
Probing the proteome.Nat Biotechnol. 2025 Aug;43(8):1216-1220. doi: 10.1038/s41587-025-02737-2. Nat Biotechnol. 2025. PMID: 40595414 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources